Detalles de la búsqueda
1.
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R.
ESMO Open
; 9(6): 103464, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833971
2.
[Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)]. / A la dose identique de 10 mg/j, la rosuvastatine est plus efficace que l'atorvastatine pour atteindre l'objectif de LDL-cholestérol < 1,00 g/l chez les patients à haut risque cardiovasculaire (étude ARIANE).
Ann Cardiol Angeiol (Paris)
; 56(2): 82-7, 2007 Apr.
Artículo
en Francés
| MEDLINE | ID: mdl-17484092
Resultados
1 -
2
de 2
1
Próxima >
>>